Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say

India’s pharmaceutical sector has given its insights into US President Donald Trump’s announcement of a 25 per cent tariff on all Indian imports starting August 1, warning that the move could significantly disrupt American healthcare rather than weaken Indian industry. While uncertainty remains about whether pharmaceuticals will fall under the new tariff list- given Trump’s…

Read More

TCS Q1 revenue falls 3%, 1st drop in over 4 years

Bengaluru: TCS marked its first year-on-year decline in constant currency since the Sept quarter of FY21, with lacklustre performance attributed to weak macroeconomic conditions, cautious client sentiment, delayed decision-making, and the winding down of the BSNL deal. Its revenue for the June quarter fell 3.1% year-on-year in constant currency and 3.3% sequentially, as geopolitical uncertainties…

Read More